Department of Pediatrics, University of California, San Diego, California, USA.
Pfizer, Biotherapeutics Pharmaceutical Sciences, Andover, Massachusetts, USA.
Biotechnol Bioeng. 2021 May;118(5):2118-2123. doi: 10.1002/bit.27714. Epub 2021 Feb 19.
The control of nutrient availability is critical to large-scale manufacturing of biotherapeutics. However, the quantification of proteinogenic amino acids is time-consuming and thus is difficult to implement for real-time in situ bioprocess control. Genome-scale metabolic models describe the metabolic conversion from media nutrients to proliferation and recombinant protein production, and therefore are a promising platform for in silico monitoring and prediction of amino acid concentrations. This potential has not been realized due to unresolved challenges: (1) the models assume an optimal and highly efficient metabolism, and therefore tend to underestimate amino acid consumption, and (2) the models assume a steady state, and therefore have a short forecast range. We address these challenges by integrating machine learning with the metabolic models. Through this we demonstrate accurate and time-course dependent prediction of individual amino acid concentration in culture medium throughout the production process. Thus, these models can be deployed to control nutrient feeding to avoid premature nutrient depletion or provide early predictions of failed bioreactor runs.
营养物质可用性的控制对于生物疗法的大规模生产至关重要。然而,蛋白质氨基酸的定量分析既耗时又难以实时实施原位生物过程控制。基因组规模的代谢模型描述了从培养基营养物质到增殖和重组蛋白生产的代谢转化,因此是一种用于氨基酸浓度的计算监测和预测的有前途的平台。由于未解决的挑战,这一潜力尚未实现:(1)这些模型假设了一种最优和高效的新陈代谢,因此往往会低估氨基酸的消耗;(2)这些模型假设了一种稳态,因此预测范围较短。我们通过将机器学习与代谢模型相结合来解决这些挑战。通过这种方法,我们可以准确地预测培养过程中培养基中单个氨基酸浓度的时程变化。因此,这些模型可以被用来控制营养物质的供给,以避免过早耗尽营养物质,或者对生物反应器运行失败提供早期预测。